Kailera Therapeutics, Inc.
Price
Overview
Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Kailera Therapeutics, Inc., its business model, key products, and controversies.